Risk factors and guideline adherence of empiric antibiotic use in community-acquired pneumonia

S. Pascual Guardia (Barcelona, Spain), J. Marin-Corral (Barcelona, Spain), F. Amati (Milano, Italy), S. Aliberti (Milano, Italy), M. Carugati (Milano, Italy), O. Sibila (Barcelona, Spain), F. Sanz (Valencia, Spain), A. Rodriguez (Tarragona, Spain), G. Sotgiu (Sassari, Italy), P. Marcos (A.Coruña, Spain), M. Restrepo (San Antonio, United States), .. On Behalf Of Glimp Investigators (San Antonio, United States)

Source: International Congress 2022 – COPD management: comorbidities, cohorts and real-world studies

Session: COPD management: comorbidities, cohorts and real-world studies
Session type: Thematic Poster
Number: 2114

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Pascual Guardia (Barcelona, Spain), J. Marin-Corral (Barcelona, Spain), F. Amati (Milano, Italy), S. Aliberti (Milano, Italy), M. Carugati (Milano, Italy), O. Sibila (Barcelona, Spain), F. Sanz (Valencia, Spain), A. Rodriguez (Tarragona, Spain), G. Sotgiu (Sassari, Italy), P. Marcos (A.Coruña, Spain), M. Restrepo (San Antonio, United States), .. On Behalf Of Glimp Investigators (San Antonio, United States). Risk factors and guideline adherence of empiric antibiotic use in community-acquired pneumonia. 2114

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.